Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Name: Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology
SKU: 3245
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 1 Articles Tags: aliou-d-ousmanou, drug-interactions, drug-transport-protein, inducer, inhibitor, multidrug-resistance, p-glycoprotein, sheri-l-hoyler, stanley-w-carson, substrate

Description

Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Description

Stanley W. Carson

DRUG INTERACTIONS

Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Stanley W. Carson, PharmD, FCCP, BCPP, Aliou D. Ousmanou, PharmD, and Sheri L. Hoyler, PharmD

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)

Theodore J. Anfinson, MD: Akathisia, Panic, Agoraphobia, and Major Depression Following Brief Exposure to Metoclopramide

Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR

Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Description

Stanley W. Carson

DRUG INTERACTIONS

Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Stanley W. Carson, PharmD, FCCP, BCPP, Aliou D. Ousmanou, PharmD, and Sheri L. Hoyler, PharmD

Related products

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)

Theodore J. Anfinson, MD: Akathisia, Panic, Agoraphobia, and Major Depression Following Brief Exposure to Metoclopramide

Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR